Medtech company looks to use AI to diagnose migraines

Medtech company Healint is partnering with the Saitama Medical University Hospital in Japan to test how artificial intelligence could be used to diagnose migraines.

Advertisement

The study is powered by Healint’s Migraine Buddy platform for data. The migraine tracking platform has 3.5 million users, according to an April 27 Healint news release.

The study will examine how AI could diagnose patients, select treatments and identify possible fatal conditions.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.